Sunday, November 15, 2026

Psychotropic Trials on Consumers of Behavioral Health Services by Keith Torkelson MS, BS

 


Contents

  • Requirements and Specifications
  • Results Up Front
  • Results Up Front – Master Medications List
  • When a doctor tries you on a new medication is it an experiment?
  • Experimentation on Human Subjects
  • Clozapine Algorithm
  • Fleshing Issues by Medication
  • E.H.R. Experiment – Increase in Error Rate (Circa 2026)
  • Chemically validated diagnoses for mental illness
  • Typical Antipsychotics
  • Atypical Antipsychotics
  • More - How is it that Risperadone and Invega were ineffective for me?
  • Fleshing Issues by People (MDs & NPs)
  • Brain Games – Reversing or Slowing the Effects of Dementia
  • Integrated Circuits to Treat Mental Illness
  • Therapeutic changes in brain circuitry and chemistry
  • Evolution of ECT
  • What is a Chemical Lobotomy?






Results Up Front – Master Medications List – Part I of II

Not in Chronological Order




Master Medications List – Part II of II

Not in Chronological Order




When a doctor tries you on a new medication is it an experiment?

No, giving you a new medication is generally not an experiment.

Why It Is Not an Experiment

Extensive Testing First:

Before a medication is approved by agencies like the U.S. Food and Drug Administration (FDA), it undergoes years of laboratory research and Clinical Trials (Phase I–III) involving thousands of patients to prove it is safe and effective.

Tailored Treatment:

When your doctor prescribes a new medication, they rely on clinical guidelines, medical training, and your specific health history to find the best option for your condition—not to test an unknown theory on you.

Individual Response:

Every person's body reacts differently to pharmaceuticals. Adjusting a dose or switching to a different drug is a process of individualized fine-tuning, rather than scientific experimentation.

When Medication Is Experimental

A medication is considered experimental only under specific circumstances:

Clinical Trials:

You are explicitly enrolled in a structured Clinical Trials Research Study designed to answer a scientific research question.

Investigational Drugs:

You are taking a drug that has not yet received regulatory approval and is still being tested for safety or efficacy, often accessed through specialized trials or expanded access programs.

Off-Label Use:

A doctor prescribes an already-approved drug for a condition or age group it wasn't originally studied for. While common and legal, this relies on clinical experience rather than primary trial data for that specific use.

 

Experimentation on Human Subjects

Experiments on human subjects involve systematic scientific investigations—either interventional or observational—designed to collect data for medical or social science research.

Core Ethical Principles

Modern human subject research is guided by strict legal and ethical frameworks to prevent abuse and protect participants:

Voluntary Informed Consent:

Subjects must fully understand the nature, risks, and benefits of a study and agree to participate of their own free will.

Right to Withdraw:

Participants can leave a study at any time without facing penalties or loss of benefits.

Protection from Harm:

Researchers must minimize physical, psychological, or social risks.

Institutional Oversight:

Most regulated research requires approval from an Institutional Review Board (IRB) or ethics committee before it can begin.

Key Historical Milestones

Global and national guidelines were shaped largely in response to historical violations:

Nuremberg Code (1947):

Formulated after World War II in response to Nazi medical atrocities; established the absolute necessity of voluntary consent.

Declaration of Helsinki (1964):

Developed by the World Medical Association as a cornerstone guide for ethical medical research involving human subjects.

Belmont Report (1978) & Common Rule (1991):

Set the foundation for ethical research regulations in the United States, emphasizing respect for persons, beneficence, and justice.

Notable Examples of Unethical Experiments

History includes many instances where ethical principles were severely violated, often targeting prisoners, soldiers, or marginalized populations without consent:

Nazi Human Experimentation & Unit 731:

Brutal medical torture, hypothermia studies, and biological warfare tests conducted during World War II.

Tuskegee Syphilis Study:

A multi-decade U.S. Public Health Service study that withheld treatment from Black men with syphilis without their informed consent.

Project MKUltra:

Clandestine U.S. CIA experiments involving mind-altering substances like LSD and psychological interrogation techniques.

Psychological Studies:

Famous social experiments like the Stanford Prison Experiment and the Milgram obedience experiments raised serious questions about psychological harm and participant distress.


Clozapine Algorithm

We should have been tried on CloZAPine after 3-4 failures on anti-psychotics

We were a candidate in the early 1990s yet did not get on it until 2006



Fleshing Issues by Medication

Common issues and side effects caused by medicines fall into several main categories, ranging from routine reactions to severe medical risks.

Common Physical and Digestive Side Effects

Digestive discomfort:

Nonsteroidal anti-inflammatory drugs (NSAIDs), antibiotics, and iron supplements can cause nausea, diarrhea, constipation, gastritis, or stomach ulcers.

Esophageal irritation:

Pills like aspirin, doxycycline, or vitamin C can stick in the throat and cause local ulcers or bleeding if swallowed without enough water.

Drowsiness and dizziness:

Antihistamines, antidepressants, blood pressure medications, and sleep aids frequently cause fatigue, brain fog, or lightheadedness.

Balance and fall risks:

Polypharmacy (taking multiple drugs at once) and high-risk medications like sedatives or muscle relaxants increase the chance of falls, especially in older adults.

Drug Interactions

Pharmacokinetic changes:

One drug can alter how another is processed by the liver or kidneys (for example, grapefruit juice interacts with statins to raise drug levels in the blood).

Additive or dangerous effects:

Combining blood thinners with NSAIDs escalates bleeding risks, while mixing St. John's wort or herbal supplements with antidepressants can trigger life-threatening serotonin toxicity.

Severe Allergic and Systemic Reactions

Severe skin and immune reactions:

Rare but life-threatening responses include Anaphylaxis, Stevens-Johnson Syndrome (SJS), Toxic Epidermal Necrolysis (TEN), and DRESS reaction.

Symptom masking:

Using over-the-counter or temporary symptom-relief drugs without identifying the root cause can allow underlying diseases to progress dangerously.

Supply Chain and Manufacturing Issues

Generic drug quality and shortages:

A large portion of generic drug manufacturing occurs overseas, leading to occasional oversight challenges, contamination risks, and shortages of vital treatments in the United States.


E.H.R. Experiment – Increase in Error Rate (Circa 2026)

Studies show that Electronic Health Record (EHR) error rates vary widely—ranging from 15% to over 50% depending on task complexity, vendor design, and workflow delays.

Key Findings on EHR Error Rates

Operating Room Documentation:

A recent PMC study found an overall documentation error rate of 17.01%, surging from 1.30% with no delay to 38.43% for documentation delays exceeding 20 minutes 0.6.1.

Medication Errors:

Research from University of Utah Health revealed that EHR systems fail to detect up to 33% (one in three) of potentially harmful medication errors and drug interactions.

Task Variability:

A JAMIA study tracking emergency medicine ordering scenarios across Epic and Cerner systems found error rates reaching up to 50%, with an eightfold difference in required mouse clicks.

Patient-Reported Mistakes:

In a JAMA Network Open study, 1 in 5 patients who read their visit notes reported finding a mistake, with 40% perceiving the error as serious.

Main Causes of Increased Error Rates

Documentation Delays:

Rushing to catch up on delayed charting drastically spikes mistakes during high-intensity procedures.

Information Overload & Alert Fatigue:

Excessive notifications, poor interface design, and "note bloat" increase cognitive burden on clinicians.

Local Customization:

Hospitals often modify software and disable decision-support alerts independently, while federal regulations typically inspect only baseline factory software.

Copy-Paste Culture:

Reusing old text propagates outdated or inaccurate clinical information across charts.


Chemically validated diagnoses for mental illness

There are no chemically validated (biomarker-based) diagnostic tests used to confirm mental illnesses.

Clinical Assessment Only:

Psychiatric diagnoses—such as Major Depressive Disorder, Schizophrenia, Bipolar Disorder, or Anxiety—are made through clinical interviews, mental state evaluations, and standardized criteria like the DSM-5 rather than blood, urine, or brain-chemistry assays.

Excluding Physical Causes:

Lab tests (such as blood or thyroid panels, drug screens, or imaging) are ordered strictly to rule out non-psychiatric medical issues (like nutritional deficiencies, neurological tumors, or autoimmune conditions such as lupus) that can mimic psychiatric symptoms.

The "Chemical Imbalance" Myth:

The popular idea that mental health disorders are diagnosed or caused by a simple, measurable chemical imbalance in the brain is an oversimplification. While neurotransmitters, inflammation markers, and metabolomics are active areas of research, psychiatry currently relies on a bio-psycho-social model rather than objective chemical tests.



(*) Absolutely miserable medications.  Complicated anxiety and sleep issues.  Severe adverse reactions including Tardive Dyskinesia and Muscle Rigidity.



Other Medications

Risperadone (Risperdal) was ineffective for us.  Invega monthly injection was ineffective for us on two different occasions.  It makes sense that Invega would not be effective. Invega itself is not a metabolite; Invega (brand name for paliperidone) is already the active form and is the major active metabolite of the older antipsychotic medication risperidone (Risperdal).

 

More - How is it that Risperadone and Invega were ineffective for me?

Risperidone and Invega (paliperidone) are chemically almost identical, meaning that if one does not work for your body, the other is also very likely to be ineffective. When your body processes risperidone, it breaks it down into paliperidone, which is the exact active ingredient in Invega. Because both drugs act on the exact same brain pathways, they share the same core mechanism. Several biological and clinical factors can explain why neither medication worked for you.

Shared Pharmacology

The Active Metabolite Link.

Paliperidone is the primary active metabolite of risperidone. Taking Invega essentially skips the liver processing step required by risperidone, delivering the same active compound directly to your system.

Identical Receptor Targets.

Both medications work primarily by blocking specific dopamine (D2) and serotonin (5-HT2A) receptors in the brain. If your specific symptoms are not driven by this exact receptor pathway, neither medication will provide relief.

Individual & Clinical Factors

Genetic Variations in Brain Receptors.

Every person has unique variations in their dopamine and serotonin receptors. Your specific receptor makeup may simply not respond well to how these two drugs bind to them.

Diagnosis and Symptom Mismatch.

While both medications treat conditions like schizophrenia, they do not target every symptom type equally. For instance, they are generally less effective for depressive episodes or negative symptoms like low motivation and emotional blunting.

Duration Limits.

Antipsychotic medications often take several weeks to show their full effect. If treatment was stopped early or adjusted before reaching a stable regimen, the medication may not have had an adequate period to work.

Treatment Resistance.

Some individuals have conditions that do not respond to standard first-line dopamine blockers. In these cases, a completely different class of medication—such as cloZAPine or newer agents that target different brain chemicals—is often needed.

What to Discuss With Your Prescriber

Trying a Different Chemical Class.

Since both of these drugs rely on the same compound, ask your doctor about switching to an antipsychotic with a different chemical structure and receptor profile.

Reviewing Your Trial History.

Share the details of your previous regimens and how long you took each medication so your doctor can evaluate if you completed a full clinical trial.


Fleshing Issues by People (MDs & NPs)

Scored by and for Keith “Buster” Torkelson, MS, BS




These values have been updated since publishing a report card in previous studies.

(*) Dr. Dobos had bi-weekly medication management groups which was the most efficient manner to handle a caseload that we ever experienced.  Unfortunately we went to the hospital on his watch.

(**) These scores will vary between papers and are subject to change.

 

Brain Games – Reversing or Slowing the Effects of Dementia

Brain games and cognitive exercises target specific mental skills like memory, attention, problem-solving, and speed.

 

Popular Online Platforms & Apps

 

Lumosity:

Features over 40 research-inspired games targeting memory, speed, attention, flexibility, and problem-solving.

Games for the Brain:

Offers classic browser-based logic and puzzle games like Sudoku, Chess, Checkers, Reversi, and Mahjongg.

Mind Games:

Provides a free catalog of daily word searches, nonograms, Sudoku, crosswords, and memory games.

Wordle & Variations:

Daily word puzzles like the official NYT Wordle or community-favored variations (Quordle, Octordle) help with vocabulary and pattern recognition.

 

Classic & Real-World Brain Games

 

Number Puzzles:

Sudoku and number sums build logical thinking and concentration.

Word & Language Games:

Crosswords, Scrabble, Boggle, and Taboo strengthen verbal fluency and crystallized intelligence.

Strategy & Board Games:

Chess, Checkers, Bridge, Uno, and Monopoly challenge executive function, working memory, and real-time problem-solving.

Visuospatial Puzzles:

Jigsaw puzzles, find-the-difference sheets, and mazes help protect visuospatial functioning as you age.


Integrated Circuits to Treat Mental Illness

Modern psychiatry increasingly views mental illness—such as treatment-resistant depression and obsessive-compulsive disorder (OCD)—not merely as a chemical imbalance, but as a disorder of brain circuits. Integrated circuits, microchips, and implantable electronic devices are at the forefront of a shift toward precision neuromodulation.

How Integrated Circuits and Implants Work in Psychiatry

Deep Brain Stimulation (DBS):

Involves surgically implanting miniature electrodes or pacemaker-like devices directly into specific brain regions (such as the subgenual anterior cingulate cortex). These integrated systems deliver controlled electrical pulses to modulate and "rewire" dysfunctional neural networks.

Closed-Loop Systems:

Newer implantable and wearable technologies are designed to monitor real-time brain activity and deliver stimulation only when specific biomarker patterns or abnormal circuit activity are detected.

Targeting Resistant Conditions:

These hardware approaches are primarily studied and deployed for patients with severe, treatment-resistant major depressive disorder (TRD) or debilitating OCD who have not responded to psychotherapy or multiple medications.

Non-Invasive Alternative Circuit Therapies

For patients who do not require or want surgical implants, circuit-level modulation is also achieved via non-invasive tools:

Transcranial Magnetic Stimulation (TMS):

Uses external electromagnetic coils placed on the scalp to stimulate mood-regulating brain regions like the dorsolateral prefrontal cortex without anesthesia or surgery.

Electroconvulsive Therapy (ECT):

A well-established clinical therapy that uses regulated electrical currents under anesthesia to induce therapeutic changes in brain circuitry and chemistry for severe episodes.

 


Therapeutic changes in brain circuitry and chemistry

Therapeutic interventions—including psychotherapy, pharmacotherapy, and neuromodulation—induce measurable structural and chemical adaptations in the brain through neuroplasticity.

Changes in Brain Circuitry (Structure & Activity)

Prefrontal Cortex (PFC):

Talk therapy and cognitive behavioral approaches strengthen top-down emotional regulation by increasing functional activity and gray matter volume in executive control regions.

Amygdala and Limbic System:

Overactive alarm centers that drive fear, anxiety, and hyper-reactivity show reduced baseline volume and decreased hyper-reactivity following successful treatment.

Synaptic Remodeling:

Interventions promote the growth of new dendritic spines and prune outdated or stress-induced connections, allowing neural circuits to reorganize.

Targeted Circuit Stimulation:

Advanced approaches like Vagus Nerve Stimulation or deep-brain stimulation directly target specific white-matter pathways (such as the subcallosal cingulate) to reset malfunctioning loops in treatment-resistant conditions.

Changes in Brain Chemistry (Neurotransmitters & HPA Axis)

Serotonin and Dopamine:

Therapeutic modalities elevate availability and receptor sensitivity for key mood-stabilizing and reward-regulating neurotransmitters.

GABA and Glutamate:

Treatments enhance inhibitory neurotransmission via GABA while dialing down excessive excitatory glutamate and norepinephrine signaling.

BDNF (Brain-Derived Neurotrophic Factor):

Therapy and lifestyle interventions trigger BDNF release, which supports the survival of existing neurons and encourages the growth of new synapses.

Stress Hormone Regulation:

Modulating the hypothalamic-pituitary-adrenal (HPA) axis lowers chronic cortisol output, protecting the hippocampus from stress-induced volume loss.

 

Would you like to explore how a specific intervention (such as Cognitive Behavioral Therapy, antidepressants, or mindfulness) affects a particular mental health condition?

 
Evolution of ECT

Electroconvulsive therapy (ECT) has evolved from a crude, unanesthetized chemical and electrical intervention into a highly regulated, safe, and precise neuromodulation procedure.

Key Stages of Evolution

Pre-ECT Chemical Convulsive Era (1930s): The practice grew out of early theories that induced seizures could alter mental illness. Ladislas J. Meduna used intramuscular camphor and later Metrazol (cardiazol) to chemically induce seizures in patients with schizophrenia, though it caused severe pre-seizure panic and high physical risk.

Invention of Electrical ECT (1938): Italian psychiatrists Ugo Cerletti and Lucio Bini replaced chemical agents with controlled electrical currents delivered to the scalp, performing the first human ECT treatment in Rome.

The "Unmodified" Era (1938–1950s):

Early ECT was administered "unmodified"—meaning without anesthesia or muscle relaxants. High-voltage alternating currents (AC) induced violent motor convulsions that occasionally led to bone fractures, dental injuries, and severe post-procedure confusion.

Introduction of Anesthesia and Muscle Relaxants (1940s–1952):

Wladimir T. Liberson (1944) shortened stimulus durations, reducing cognitive blunting.

General anesthesia and barbiturates were introduced for patient comfort.

Paralytic muscle relaxants—initially curare and later replaced by succinylcholine (1952)—eliminated violent physical muscle contractions while preserving the therapeutic brain seizure ("modified ECT").

Refinement of Electrical Waveforms and Placement (1970s–Present):

Brief-pulse and ultrabrief-pulse stimuli replaced traditional sine waves, drastically cutting down memory impairment and cognitive side effects.

Unilateral ECT (applying electrodes to only one hemisphere) was adopted alongside traditional bilateral placement to further protect memory function.

Modern Status:

Today, ECT is recognized as a vital, fast-acting treatment for severe, treatment-resistant depression, acute mania, catatonia, and psychotic depression, backed by safety standards and continuous innovations like magnetic seizure therapy.

 


What is a Chemical Lobotomy?

A chemical lobotomy is a non-medical, descriptive term used to describe the heavy sedation and emotional flattening caused by certain powerful psychiatric or sedative medications—most historically antipsychotics like chlorpromazine (Thorazine).

Origins and History

The Rise of Antipsychotics:

In the early 1950s, the introduction of early antipsychotic drugs like chlorpromazine revolutionized psychiatric care. Because these drugs rapidly calmed, quieted, and sedated agitated or psychotic patients without physical surgery, observers and historians dubbed them a "chemical lobotomy".

Replacing Physical Surgery:

Before these medications became widespread, severe mental health conditions were sometimes treated with physical psychosurgery (such as standard or transorbital lobotomies) or harsh shocks. Drugs offered a non-surgical, more predictable way to manage symptoms, though they carried their own intense sedative and neurological side effects.

Common Meanings and Contexts

Historical/Medical Metaphor:

Originally applied to the first generation of major tranquilizers and antipsychotics that suppressed acute mania, hallucinations, or severe agitation.

Critiques of Long-Term Medication:

In modern discussions, critics, patients, or advocacy groups sometimes use the term colloquially to describe the side effects of prolonged or high-dose psychiatric medications (such as antipsychotics, mood stabilizers, or heavy painkillers). These effects can include:

Emotional numbing or apathy

Cognitive dullness or brain fog

Chronic fatigue and physical sluggishness

Involuntary movements or tremors





No comments:

Post a Comment